Quantum BioPharma Ltd.

Informe acción DB:0K91

Capitalización de mercado: €8.0m

Quantum BioPharma Dirección

Dirección controles de criterios 4/4

Quantum BioPharma's CEO is Zeeshan Saeed, appointed in Jul 2021, has a tenure of 3.33 years. total yearly compensation is $599.87K, comprised of 37.1% salary and 62.9% bonuses, including company stock and options. directly owns 6.29% of the company’s shares, worth €505.28K. The average tenure of the management team and the board of directors is 3.2 years and 3.2 years respectively.

Información clave

Zeeshan Saeed

Chief Executive Officer (CEO)

US$599.9k

Compensación total

Porcentaje del salario del CEO37.1%
Permanencia del CEO3.3yrs
Participación del CEO6.3%
Permanencia media de la dirección3.2yrs
Promedio de permanencia en la Junta Directiva3.2yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Zeeshan Saeed en comparación con los beneficios de Quantum BioPharma?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2024n/an/a

-US$7m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$600kUS$223k

-US$18m

Sep 30 2023n/an/a

-US$23m

Jun 30 2023n/an/a

-US$29m

Mar 31 2023n/an/a

-US$31m

Dec 31 2022US$774kUS$239k

-US$27m

Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$25m

Mar 31 2022n/an/a

-US$30m

Dec 31 2021US$1mUS$225k

-US$34m

Sep 30 2021n/an/a

-US$32m

Jun 30 2021n/an/a

-US$39m

Mar 31 2021n/an/a

-US$30m

Dec 31 2020US$899kUS$212k

-US$28m

Sep 30 2020n/an/a

-US$36m

Jun 30 2020n/an/a

-US$35m

Mar 31 2020n/an/a

-US$41m

Dec 31 2019US$2mUS$249k

-US$34m

Sep 30 2019n/an/a

-US$38m

Jun 30 2019n/an/a

-US$25m

Mar 31 2019n/an/a

-US$16m

Dec 31 2018US$503kUS$183k

-US$17m

Compensación vs. Mercado: Zeeshan's total compensation ($USD599.87K) is about average for companies of similar size in the German market ($USD488.36K).

Compensación vs. Ingresos: Zeeshan's compensation has been consistent with company performance over the past year.


CEO

Zeeshan Saeed (54 yo)

3.3yrs

Permanencia

US$599,873

Compensación

Mr. Zeeshan Saeed serves as Executive Co-Chairman at FSD Pharma Inc. since May 24, 2018 and serves as its President since July 27, 2021 and Chief Executive Officer since June 29, 2023. He serves as Co-Chai...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Zeeshan Saeed
Founder3.3yrsUS$599.87k6.29%
€ 505.3k
Anthony Durkacz
Founder & Executive Co-Chairman6.4yrsUS$599.87k5.36%
€ 431.1k
Donal Carroll
CFO & COO3.3yrsUS$602.87k4.44%
€ 356.6k
Nathan Coyle
Controllerless than a yearUS$178.21k0.13%
€ 10.8k
Lakshmi Kotra
CEO of Lucid & Director3.2yrsUS$521.97k1.17%
€ 94.3k
Jason Sawyer
Head of Finance & Mergers and Acquisitionsless than a yearsin datossin datos
Maryann Adesso
Corporate Secretaryno datasin datossin datos
Randell Mack
President of FSD BioSciences3.7yrssin datossin datos
Andrzej Chruscinski
Vice President of Clinical & Scientific Affairs of Lucidno dataUS$110.30k0%
€ 0
Kevin Cassidy
Vice President of Quality-Lucidno dataUS$144.82ksin datos

3.2yrs

Permanencia media

48yo

Promedio de edad

Equipo directivo experimentado: 0K91's management team is considered experienced (3.2 years average tenure).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Zeeshan Saeed
Founder3.5yrsUS$599.87k6.29%
€ 505.3k
Anthony Durkacz
Founder & Executive Co-Chairman6.4yrsUS$599.87k5.36%
€ 431.1k
Lakshmi Kotra
CEO of Lucid & Director2yrsUS$521.97k1.17%
€ 94.3k
Daniele Piomelli
Member of Research & Clinical Advisory Board2.8yrssin datossin datos
Eleanor Fish
Member of Research & Clinical Advisory Board3yrssin datossin datos
Hance Clarke
Member of Research & Clinical Advisory Board3.2yrssin datossin datos
Eric Hoskins
Independent Director1.5yrssin datossin datos
Adnan Bashir
Independent Director3.4yrsUS$139.37k0.0077%
€ 620.5
Peter Stys
Member of Research & Clinical Advisory Board3.2yrssin datossin datos
Shannon Dunn
Member of Research & Clinical Advisory Board3.2yrssin datossin datos
Albert Wong
Member of Research & Clinical Advisory Board3.2yrssin datossin datos
Joga Gobburu
Member of Regulatory Advisory Board3yrssin datossin datos

3.2yrs

Permanencia media

54yo

Promedio de edad

Junta con experiencia: 0K91's board of directors are considered experienced (3.2 years average tenure).